How is presbyopia managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Presbyopia

Presbyopia management includes both nonsurgical and surgical approaches, with eyeglasses, contact lenses, and FDA-approved pilocarpine 1.25% (Vuity) being the primary first-line options for most patients. 1

Nonsurgical Management Options

Eyeglasses

  • Reading glasses: Single vision lenses for near tasks
  • Bifocal lenses: Distinct segments for distance and near vision
  • Trifocal lenses: Three distinct optical zones for distance, intermediate, and near vision
  • Progressive lenses: Gradual change in power from top to bottom without visible lines 1

Contact Lenses

  • Multifocal contact lenses: Provide simultaneous vision for distance and near
  • Monovision contact lenses: One eye corrected for distance, the other for near
  • Modified monovision: Multifocal lens in one eye and distance lens in the fellow eye 1

Pharmaceutical Treatment

  • Pilocarpine HCL 1.25% (Vuity): FDA-approved topical therapy that works by stimulating ciliary muscle contraction and miosis
    • Important safety note: Retinal detachment and retinal tear have been reported with miotics
    • Precaution: Dilated fundus examination is advised prior to initiation to check for retinal holes, tears, or breaks
    • Risk factor: Patients with pre-existing retinal disease are at increased risk 1

Surgical Management Options

Keratorefractive Surgery

  • Excimer laser photoablation: Most widely used surgical approach
    • Includes PRK, LASEK, epi-LASIK, LASIK, and refractive lenticule extraction
  • Monovision correction: Distance correction for dominant eye, near correction for non-dominant eye
  • Best candidates: Patients over 40 who prioritize freedom from optical aids and accept reduced stereoacuity
  • Preoperative assessment: Trial with contact lenses to determine desired refractive endpoint 1

Corneal Inlays

  • Kamra inlay: FDA-approved aperture inlay that enhances depth of focus
  • Note: Raindrop inlay was withdrawn from market due to complications 1

Intraocular Surgery

  • Refractive lens exchange: Removal of crystalline lens with IOL implantation
  • IOL options:
    • Monofocal IOLs (for monovision)
    • Multifocal IOLs
    • Accommodative IOLs
    • Extended depth of focus IOLs
    • Light-adjustable IOLs
    • Toric IOLs (for astigmatism correction) 1

Clinical Decision Algorithm

  1. Initial assessment:

    • Determine patient's visual needs, lifestyle, and occupational requirements
    • Assess ocular health, including retinal examination
  2. First-line options (start with least invasive):

    • Eyeglasses (reading, bifocal, trifocal, or progressive)
    • Contact lenses (if patient is suitable candidate)
    • Pilocarpine 1.25% (for patients seeking pharmaceutical option)
  3. Consider surgical options when:

    • Patient desires freedom from optical aids
    • Patient is intolerant to contact lenses
    • Patient has specific lifestyle needs not met by nonsurgical options
  4. Preoperative testing for surgical candidates:

    • Monovision trial with contact lenses
    • Dominant eye testing
    • Thorough ocular examination including corneal topography and retinal evaluation

Important Considerations and Pitfalls

  • Monovision caveats:

    • May reduce contrast sensitivity and stereopsis
    • Patients with previous strabismus, phorias, or intermittent tropias may develop diplopia
    • Even with successful monovision, patients may still need glasses for night driving 1
  • Surgical risks:

    • Refractive lens exchange carries risk of retinal detachment (1.5-8.1% in myopic patients)
    • Other potential complications include endophthalmitis, suprachoroidal hemorrhage, cystoid macular edema, corneal edema, and IOL dislocation 1
  • Patient expectations:

    • No current solution fully overcomes presbyopia in all patients 2
    • Patients should understand that compromise is often necessary between distance and near vision
  • Global impact:

    • Presbyopia affects approximately 1.8 billion people worldwide
    • Over half lack adequate presbyopic correction 1
    • Untreated presbyopia negatively affects quality of life and workplace productivity 3

By following this structured approach to presbyopia management, clinicians can help patients select the most appropriate correction strategy based on their individual needs, ocular health, and lifestyle requirements.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Presbyopia: Effectiveness of correction strategies.

Progress in retinal and eye research, 2019

Research

[TREATMENTS FOR PRESBYOPIA].

Harefuah, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.